The transcriptional profiles of MSC reveal two characteristic signatures: a CXCL12-low inflammatory and leukemia expansion-like niche that likely supports leukemic burden and a CXCL11 high immune-suppressive and leukemia-initiating cell (SLIC)-like niche, where LICs are likely sustained. Here, CXCL11 is linked to leukemia.